Background. Recent clinical studies have shown that the number of interstitial mast cells increases in various types of renal disease and correlates well with the magnitude of interstitial fibrosis. The present study was conducted to assess the role of mast cells in renal fibrosis by examining an experimental glomerular disease.
that mast cells are involved in a number of allergic inflammatory diseases as well as in host defense against pathogens. In addition, several lines of evidence suggest that mast cells may participate in fibrotic processes. Mast cells are found in fibrogenic lesions in various tissues in human diseases, such as pulmonary fibrosis [1, 2] , hepatic cirrhosis [3, 4] , scleroderma [5, 6] , and keloid [7] . Mast cells serve as a rich source of several mediators [8] , including histamines, proteoglycans, and proteolytic enzymes (proteases), as well as a number of cytokines [9] , some of which are reported to be mitogenic [10] and chemotactic [11] for fibroblasts, and to stimulate the production of the extracellular matrix (ECM) by fibroblasts [9, 10, 12] . Furthermore, mast cells themselves produce components of the ECM [13] . Therefore, for these reasons they are considered to play a profibrogenic role in the above-mentioned diseases.
In recent years, mast cells were shown to be present in the interstitial area of human renal biopsy tissues from patients with various renal diseases, such as IgA nephropathy [14] [15] [16] , rapidly progressive glomerulonephritis [17] , focal and segmental glomerulosclerosis [15] , diabetic nephropathy [15, 18] , and kidney graft rejection [16, 19, 20] . Furthermore, the number of interstitial mast cells in these glomerular diseases correlates well with the degree of interstitial fibrosis. Tubulointerstitial lesions including interstitial fibrosis are considered to be prognostic features of various glomerular diseases; regardless of its primary causes, decreased renal function correlates most closely with pathologic changes in the tubulointerstitium, which include interstitial fibrosis, tubular atrophy, and loss of peritubular capillaries [21, 22] . Based on these observations, mast cells are suggested to contribute to the renal deterioration in glomerular diseases by inducing interstitial fibrosis [14, 15, 17] . However, there have been no studies that directly show the involvement of mast cells in the pathogenesis of interstitial fibrosis in the kidney.
To elucidate the role of mast cells in the interstitial fibrosis in progressive glomerular diseases, we investigated the accumulation of mast cells in an animal model of glomerular disease that is accompanied by interstitial fibrosis and renal deterioration. Furthermore, we utilized mast cell-deficient Ws/Ws rats to test if mast cells contribute to the development of the interstitial fibrosis. Ws/Ws rats have very few mast cells in their skin and other tissues [less than 1% of the number in control (+/+) littermates] because of a small deletion in the tyrosine kinase domain of the c-kit gene [23] [24] [25] . Unexpectedly, in this study we found that the degree of interstitial fibrosis was more severe in Ws/Ws rats than in the control littermates, suggesting that mast cells do not contribute to the development of interstitial fibrosis in this model. Rather, they may actually play a beneficial role in the process of fibrosis in the kidney.
METHODS

Animal model
Puromycin aminonucleoside (PAN) nephrosis model was induced in male mast cell-deficient Ws/Ws and their normal +/+ littermates (Japan SLC; Hamamatsu, Japan, N = 12 each), weighing 140 to 160 g, by the method of Jones et al [26] , with slight modifications. In brief, left unilateral nephrectomy through a flank incision was performed on each rat under sodium pentobarbital (45 mg/kg body weight) anesthesia. Five days after the nephrectomy, the rats received an intraperitoneal (i.p.) injection of PAN (Sigma Chemical Co., St. Louis, MO, USA) dissolved in 0.9% saline (15 mg/mL) and given at a dose of 15-mg/100 g body weight. Second, third, and fourth doses of PAN (4.3 mg/100 g body weight, i.p.) were administered at 3, 4, and 5 weeks, respectively, after the initial dose. Control animals did not receive any surgical procedures or injections (N = 10 each). All animals were maintained on a standard rat diet and had free access to water throughout the course of the experiment. The animals were housed individually in metabolic cages to obtain 24-hour urine once every week. They were sacrificed sequentially at 2 (N = 5 each) and 6 weeks (N = 5 each except for N = 4 for PAN-injected Ws/Ws rats; see below) after the initial dose of PAN, namely, 1 week after the first and the last injections, respectively. Three of the PAN-injected Ws/Ws rats and 2 of the PAN-injected +/+ rats died of chronic renal failure by 6 weeks. These rats were found dead in their cages in the morning, and thus their kidneys could not be used for histologic studies. These animals were excluded from the subsequent analysis. At sacrifice, blood samples were collected by heart puncture under anesthesia with diethylether. The kidneys were perfused via the abdominal aorta with ice-cold saline, and pieces of renal tissues were fixed in 10% buffered formalin or periodate-lysineparaformaldehyde (PLP) solution. Pieces of renal cortex were also used for RNA preparation and hydroxyproline analysis (see below). Urinary protein was quantified by the biuret method. Levels of blood urea nitrogen (BUN) were measured with a kit designed for clinical use (Wako Pure Chemical Industries, Osaka, Japan).
Kidney tissue preparation
The kidney tissues fixed in 10% buffered formalin were embedded in paraffin, sectioned, and stained with hematoxylin and eosin, periodic acid-Schiff (PAS), or Masson trichrome. The degree of interstitial fibrosis was semiquantitatively analyzed by inspection of Masson trichrome-stained sections and graded on a scale of 0 to 3 as follows: (0), no apparent damage; (1) mild damage, with lesions involving less than 5% of the cortex; (2) moderate damage, involving 5% to 20% of the cortex; and (3) severe damage, involving more than 20% of the cortex. Pieces for cryostat sectioning were fixed in PLP solution for 4 hours, washed several times in phosphatebuffered saline (PBS) containing 7% sucrose, embedded in Tissue-Tek OCT compound (Sakura Finetek, Torrance, CA, USA), and snap-frozen.
Immunohistochemical study
To block endogenous peroxidase activity, we treated sections of frozen or paraffin-embedded kidney tissues with methanol containing 0.6% hydrogen peroxide for 15 minutes and then washed them with PBS. They were stained by the standard avidin-biotin peroxidase technique with sheep antirat mast cell protease (RMCP) I (mast cell-specific antibody; Moredun, Scotland, UK), mouse monoclonal antibody ED-1 (specific for rat monocytes/macrophages), W3/25 (CD4 + cells), or OX8 (CD8 + cells) at 4 • C overnight. The sections were incubated with the corresponding second antibodies, biotinylated donkey antisheep IgG or horse antimouse IgG, and stained with the reagents of an ABC staining kit (Vector Laboratories, Inc., Burlingame, CA, USA). Sections were also stained with horseradish peroxidase-conjugated mouse antihuman a-smooth muscle actin (a−SMA, a marker for myofibroblasts) monoclonal antibody (Dako Corp., Carpinteria, CA, USA). All sections were then developed with 3, 3 -diaminobenzidine solution as chromogen and counterstained with methylgreen. With the aid of a 10 × 10 eyepiece grid, the numbers of monocytes/macrophages, CD4 + , and CD8 + cells in the interstitium were counted manually in 6 random nonoverlapping cortical fields (×400) of sections made from each experimental animal. RMCP I-positive interstitial mast cells were also counted in 20 random cortical fields (×100). The results of cell counting were expressed as the number per square millimeter.
Cell cultures
A cell line of renal fibroblasts (NRK49F) derived from rat kidney was obtained from The European 
All of the PCR reactions were performed as described in the Methods section.
Collection of Cell Cultures (Salisbury, UK) and maintained in Dulbecco's modified Eagle's medium (Invitrogen, Grand Island, NY, USA) supplemented with 10% fetal calf serum (FCS), glutamine, and nonessential amino acid equilibrated with 5% CO 2 -95% air at 37 • C. For experiments, cells grown to 80% confluence in 100-mm dishes were exposed to fresh medium with or without 100 lg/mL heparin (sodium salt; Sigma) for 6 hours and then used for RNA preparation.
Reverse transcription-polymerase chain reaction (RT-PCR)
Total RNA fractions were prepared from pieces of renal cortex or cultured cells by the guanidinium thiocyanate-phenol-chloroform method [27] , and 5 lg of RNA was reverse-transcribed by use of oligo(dT) primers in 20 lL of buffer as previously described [28] . For the analysis of levels of mRNA for RMCPs II, V, and VIII, 1 lL of this reaction mixture containing the cDNA was amplified by PCR in 50 lL of 10 mmol/L Tris-HCl (pH 9.0) containing 50 mmol/L KCl, 1.5 mmol/L MgCl 2 , 5 and 3 primers (Table 1) , and Taq DNA polymerase (Promega, Madison, WI, USA). Aliquots were electrophoresed on a 2% agarose gel and visualized with ethidium bromide under ultraviolet illumination. For the quantitative measurement of cytokine mRNA levels, real-time PCR was performed by using an ABI PRISM 7700 Sequence Detector and TaqMan Pre-Developed Assay Reagents for Gene Expression Quantification System (Applied Biosystems, Foster City, CA, USA). Using multiple reporter dyes, we assayed the mRNA levels of each cytokine and endogenous control (GAPDH) in the same tube and expressed cytokine mRNA levels as the ratio relative to the endogenous control.
Hydroxyproline analysis
The amount of hydroxyproline in the renal cortex was measured according to Kivirikko et al [29] as an index of collagen content. At sacrifice, pieces of renal cortex for the hydroxyproline assay were weighed, snap-frozen in liquid nitrogen, and stored at −80 • C for subsequent use. The samples were hydrolyzed in 1 mL of 6N hydrochloric acid at 110 • C for 18 hours in tightly capped tubes. After the hydrolysates had been neutralized with sodium hydroxide, their hydroxyproline content was assessed colorimetrically at 560 nm with p-dimethylaminobenzaldehyde. Results were expressed as ng per mg wet renal cortex.
Statistical analysis
All values were expressed as the mean ± SD. Data were analyzed by the Mann-Whitney U test, and a difference with a value of P < 0.05 was considered to be statistically significant.
RESULTS
PAN nephrosis in Ws/Ws and +/+ rats
In PAN nephrosis model induced by uninephrectomy and subsequent administration of PAN, increases in urinary protein excretion and BUN level were observed in both mast cell-deficient Ws/Ws and their control (+/+) littermates; there was no difference in either parameter between the two groups ( Fig. 1 ). At 6 weeks, the level of urinary protein excretion markedly decreased because of the loss of functioning nephrons (end-stage renal failure).
Renal fibrosis induced in Ws/Ws and +/+ rats by PAN
Interstitial fibrosis occurred in both PAN-treated Ws/Ws and +/+ rats at 2 weeks at the border of the cortexmedulla. A significant expansion of the fibrotic area was observed at 6 weeks in both strains. Unexpectedly however, the fibrosis was more severe in the Ws/Ws rats than in their +/+ littermates (Fig. 2 ). No obvious fibrosis was observed in the control animals. The magnitude of fibrosis was semiquantitatively determined with light microscopy (Fig. 3 ). The degree of fibrosis was similar in both groups at 2 weeks, but was greater in Ws/Ws rats than in +/+ rats at 6 weeks.
To confirm these histologic results, we measured the hydroxyproline content in the renal cortex ( Fig. 4) . At 2 weeks, although the content of this collagen marker in PAN-treated animals was slightly higher than that in control animals, the difference was not statistically significant; and the level was similar in PAN-treated Ws/Ws and +/+ rats. At 6 weeks, the content was significantly greater in PAN-treated animals than in control animals. Moreover, the level in the PAN-treated Ws/Ws rats was significantly higher than that in the PAN-treated +/+ rats. Thus, the fibrotic changes in the interstitium assessed by both histologic and biochemical methods were greater in Ws/Ws rats than in their +/+ littermates.
Interstitial mast cells in PAN-induced nephrosis
Mast cells were immunohistochemically identified by their immunoreactivity, indicating the presence of RMCP I, a specific marker for mast cells [30, 31] . An almost complete absence of mast cells in the skin of Ws/Ws rats was confirmed by immunostaining for RMCP I (data not shown). Practically no mast cells were detectable in the kidney of control Ws/Ws and +/+ rats. However, in the kidney tissues of PAN-treated +/+ rats, mast cells were observed in the interstitium, where they showed a scattered distribution (Fig. 5A ). Most were localized in the peritubular region (Fig. 5B) .
To confirm the increase in the number of mast cells in the kidney, we also examined mRNA levels of other specific markers for mast cells (i.e., RMCPs II, V, and VIII). By RT-PCR analysis, mRNAs for all of these proteases were consistently found in disease-induced rats, but not in control rats, by the experimental procedures used (Fig. 6) .
The time-kinetics of the number of interstitial mast cells determined by immunohistochemistry is illustrated in Figure 7 . After administration of PAN, the number of mast cells increased significantly in both Ws/Ws and +/+ rats, but was lower in the former than in the latter. While the number of mast cells gradually increased in PAN-treated +/+ rats with the expansion of the interstitial fibrosis, the number in PAN-treated Ws/Ws rats decreased with the continued expansion. The number in PAN-treated Ws/Ws rats was one half at 2 weeks and one fifth at 6 weeks compared with that in the PAN-treated +/+ rats.
Other interstitial cells in PAN-induced nephrosis
Because thymocytes are c-kit-positive cells, the defect in c-kit carried by Ws/Ws rats could potentially affect T-cell development, although there have been no reports showing such T-cell deficits. It is also known that myofibroblasts express c-kit [32] . To clarify the influence of the c-kit deletion in these types of cell in the kidney of Ws/Ws rats, we examined the levels of monocytes/macrophages, CD4−, CD8−, and a−SMA-positive cells in the interstitium ( Table 2 ). Low numbers of these types of cells were detected in the interstitium of the control animals. After the disease induction, their numbers increased in both Ws/Ws and +/+ rats, but there were no differences in them between the two strains. Most of the monocyte/macrophages and CD4− and CD8-positive cells were found in the interstitial lesion in clusters, especially in the area around glomeruli and disrupted tubuli, and the localization was different from that of the mast cells.
Cytokine mRNA levels in renal cortex
To investigate the possible mechanism for the increase in fibrosis in these Ws/Ws rats, we measured mRNA levels of cytokines that might affect the progression of fibrosis. As shown in Figure 8 , the levels of mRNA for two potentially profibrotic cytokines, TGF-b and interleukin (IL)-4, were higher in the Ws/Ws rats than in the +/+ ones. The differences between the two groups in the level of TGF-b mRNA at 2 weeks, and in that of IL-4 mRNA at 6 weeks, were statistically significant. There were no differences in mRNA levels of IL-2, IL-10, and interferon (IFN)-c in the renal cortex between the two strains. These results suggest that the enhanced production of TGF-b and/or IL-4 in Ws/Ws rats may have caused the enhanced fibrosis in the kidney. 
Effect of heparin on the expression of TGF-b1 mRNA in renal fibroblast in culture
Although mast cells have been shown to produce TGFb and IL-4 in culture [9] , they also produce other cytokines and factors that may modulate the production of these cytokines by other types of cells. Heparin is a major component stored in secretory granules of mast cells and is known to influence cytokine production in culture [33] . Therefore, using a cell line of interstitial fibroblasts derived from normal rat kidney, we investigated if heparin could influence the production of TGF-b in culture. As shown in Figure 9 , the expression of TGF-b mRNA in renal fibroblast was inhibited by heparin.
DISCUSSION
In progressive human glomerular diseases, regardless of their type, the number of interstitial mast cells increases as interstitial fibrosis expands [14, 15, 17] . The present study has demonstrated that in PAN nephrosis, a rat model of progressive glomerular disease, the number of interstitial mast cells also increased concomitant with the expansion of interstitial fibrosis. We also found that the number of interstitial mast cells increased in the crescentic glomerulonephritis model in Wistar Kyoto rats (our unpublished observations). These results indicate that, like in humans, mast cells accumulate in the interstitial area in progressive renal diseases in rats when interstitial fibrosis develops. Because PAN nephrosis can be induced in any strain of rat, using mast cell-deficient Ws/Ws rats, we then investigated the suggested causal link between mast cell accumulation and interstitial fibrosis. Unexpectedly, interstitial fibrosis was markedly worse in these rats. Although mast cells were not completely absent in the diseased kidney of Ws/Ws rats, their number at 6 weeks in PAN-treated Ws/Ws rats was approximately one fifth of that in the PAN-treated control littermates. Because it was shown that the number of mast cells in the whole body of Ws/Ws rats is decreased by aging [23] , we considered that the decrease in the number of interstitial mast cells from 2 to 6 weeks in the rats resulted from aging and is irrelevant to the development of interstitial fibrosis. The observed interstitial mast cells in the Ws/Ws rats may have resulted from the accumulation of the remaining small number of mast cells from other parts of the body [34] . In contrast, there were no differences between the two strains in the levels of interstitial T lymphocytes and myofibroblasts, two types of cell that could be affected by the c-kit gene mutation in Ws/Ws rats. Taken together, these results suggest that the reduction in the number of interstitial mast cells in Ws/Ws rats resulted in the exacerbation of interstitial fibrosis in this model. It was demonstrated earlier that myofibroblast proliferation is paralleled by or precedes the development of interstitial fibrosis in human and animal models [35] , but the result of the present study is not consistent with those previous studies. It could be possible that there is some unknown effect that originated from the mutated c-kit gene that changed the functions of myofibroblasts in Ws/Ws rats. In addition, we cannot exclude the possibility that the mutated c-kit gene causes other abnormalities than mast cell deficiency, although there have been no reports so far that show such defects in Ws/Ws rats except for anemia in their early life [23] . Our present study using mast cell-deficient Ws/Ws is the first one to our knowledge to reveal the role of mast cells in renal fibrosis. There have been some earlier studies in which the involvement of mast cells in fibrosis of lung [36, 37] , liver [36, 38] , and skin [39, 40] was examined by using mast cell-deficient W/W v mice and/or Ws/Ws rats. Some of these studies showed no difference in the magnitude of fibrosis between the mast cell-deficient an-imals and their control +/+ littermates, which suggested that mast cells do not appear to be necessary for the induction of fibrosis. In the present study, our histologic and biochemical analysis revealed that the fibrosis was more severe in Ws/Ws rats than in +/+ littermates at 6 weeks after the induction of PAN nephrosis. These data are consistent with other studies on lung [36, 37] and liver [36] fibrosis, which showed that the increase in the hydroxyproline content of the tissues of deficient animals was greater than that in control +/+ littermates.
The mechanism by which greater renal interstitial fibrosis occurred in Ws/Ws rats with PAN nephrosis is unclear. We investigated the possibility that levels of cytokines that potentially enhance directly or indirectly the progression of fibrosis are changed in Ws/Ws rats with PAN nephrosis. The cytokines tested in this study included Th1 and Th2 cytokines, the balance of which is suggested to affect fibrotic changes [41] . Our results showed that mRNA levels of TGF-b and IL-4 were higher in Ws/Ws rats than in controls in the PAN nephrosis model, suggesting that the deficiency of mast cells (i.e., in Ws/Ws rats) may have caused an increase in their expression, resulting in more fibrosis in the Ws/Ws rats. Mast cells contain a variety of mediators that have been shown to directly or indirectly affect the progression of fibrosis in tissues [42] . Although mast cells have been shown to produce TGF-b and IL-4 in culture [9] , they also produce other cytokines and factors that may modulate cytokine production by other types of cells. Heparin, a major component stored in secretory granules of mast cells, was shown to have effects on cell proliferation [43] and cytokine production [33] , both of which are involved in the pathogenesis of fibrosis. Heparin was also shown to inhibit DNA synthesis by human renal fibroblasts when added alone, although it enhanced DNA synthesis when added with tryptase, a proteolytic enzyme secreted by mast cells [44] . The present study demonstrated that heparin inhibited the gene expression of TGF-b, the most potent fibrogenic cytokine, in renal fibroblasts in culture. A recent study also demonstrated that heparin inhibited the production of TGF-b by cultured human proximal tubular epithelial cells, another source of the cytokine in diseased kidney [45] . Therefore, it is conceivable that heparin secreted from mast cells may inhibit TGF-b production by these cells in the diseased kidney and that this action may have contributed to the less fibrosis in the control +/+ littermates in the PAN nephrosis model. We also tested the effect of heparin on IL-4 production by these cells, but the production level was very low, and thus the effect of heparin could not be detected (our unpublished observation).
The results of the present study using mast celldeficient animals seem to be in conflict with a suggested role of mast cells in renal diseases. The profibrogenic role of mast cells has been proposed mostly based on histologic observations of clinical samples and results of in vitro studies using cultured cells [14] [15] [16] [17] [18] [19] [20] 44 ]. However, the histologic studies only showed a correlation between the two phenomena, mast cell accumulation and fibrosis, and do not provide evidence of a causal link between them. In vitro studies, on the other hand, give data on the potential effects of mast cells or their secretory components on fibrosis, but do not provide information about the overall effect of mast cells. Even if whole components stored in mast cells or mast cells themselves are used in a culture system, one cannot provide all cells and extracellular circumstances of the kidney in the in vitro system. Further studies are needed to elucidate the role of mast cells in the mechanism of fibrosis, but we consider that experiments using animal models as well as intervention studies in humans will be necessary to assess the effect of mast cells as a whole on fibrosis.
In the kidney of the animal models of glomerular diseases we tested, mast cells were localized in a scattered distribution in the interstitium, whereas interstitial mononuclear cells (MNC), mostly consisting of monocytes/macrophages and T lymphocytes, were present in clusters. In human glomerular diseases on the other hand, mast cells were restricted to the area of interstitial fibrosis where only a few T lymphocytes and macrophages were concomitantly present, but were rarely found in the interstitial lesion where the influx of MNC was pronounced (our unpublished observations). This interstitial influx of MNC presumably precedes the interstitial fibrosis and is suggested to be involved in the mechanism of fibrotic changes [46] . Therefore, in consideration of these findings, together with the results of the present study, it is conceivable that mast cells are not involved in the development of fibrosis because of their absence in prefibrotic lesions in contrast to T lymphocytes or macrophages, but are attracted in fibrotic lesion and possibly participate in the attenuation or resolution of the fibrotic lesions. Unfortunately, in the rodent models it was rather difficult to discriminate prefibrotic lesions from established areas of fibrosis, probably because of the short duration and/or acute inflammation after the disease onset.
CONCLUSION
In the present study, we investigated the role of mast cells in the development of renal fibrosis by using mast cell-deficient rats. In human studies, mast cells are thought to be one of the cell types contributing to the interstitial fibrosis. However, it could be mentioned from our data that mast cells are not simply fibrogenic. Rather, they might have a potential to be protective or ameliorative in this model and possibly in other models and also in humans.
